Technology Platforms

The CynoCure™ platform is our cutting-edge solution for canine therapeutic antibody discovery and development. Built upon a foundation of canine-specific immunology, bioinformatics, and molecular engineering, CynoCure™ enables the rapid identification, optimization, and production of high-affinity antibodies tailored to the dog immune system. This platform integrates advanced technologies such as phage display, ensuring both diversity and precision in antibody generation. From target validation to lead optimization and functional characterization, CynoCure™ streamlines every step of the R&D pipeline, helping our partners create effective, species-specific biologics for conditions such as cancer, autoimmune disease, and infectious disorders in dogs.

The FeliCure™ platform is uniquely designed for feline biotherapeutic development, addressing the distinct immunological and molecular characteristics of cats. With specialized libraries, expression systems, and cell-based assay tools optimized for feline biology, FeliCure™ enables the efficient discovery and development of monoclonal and multi-specific antibodies that demonstrate superior binding and functionality in feline models. This platform supports programs targeting key diseases such as Feline Infectious Peritonitis (FIP), chronic kidney disease, allergy, and metabolic disorders. FeliCure™ provides a complete, reliable workflow, from antigen design and antibody selection to in vitro and in vivo validation, empowering innovators to advance feline therapeutics with confidence and precision.

• Species-Specific Expertise
  We specialize exclusively in dogs and cats, ensuring every discovery platform, reagent, and workflow is scientifically optimized for companion animal health.
• Integrated Technology Platforms
  Our proprietary CynoCure™ and FeliCure™ platforms combine next-generation antibody discovery technologies with deep veterinary insight, accelerating therapeutic innovation.
• End-to-End R&D Capabilities
  From antigen design to functional validation and preclinical testing, we offer complete, in-house support to streamline development and ensure quality.
• Collaborative Partnership Model
  We work closely with veterinary pharmaceutical companies, biotech innovators, and academic teams, providing flexible solutions that turn scientific vision into real-world treatments.